Business Context and Reporting Period
Company: BioXcel Therapeutics, Inc. (BTAI)
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2026
Reporting Period Covered: Three months and full year ended December 31, 2025
This filing serves as a notification that the Company issued a press release on March 27, 2026, announcing financial results for the periods ended December 31, 2025, and providing a business update. The detailed results are contained in Exhibit 99.1 (Press Release) and are incorporated by reference.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The text of this Form 8-K does not provide specific numerical values for revenue, net income, operating cash flow, profit margins, debt levels, or liquidity positions. These figures are disclosed in the referenced press release (Exhibit 99.1) but are not present in the body of this current report.
Material Changes
Comparison to Prior Period: The filing text does not contain specific data regarding material changes in financial performance compared to prior periods. It only confirms that such results were announced in the accompanying press release.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company provided a "business update" alongside the financial results, but the specific content of this update, including any forward-looking guidance or outlook, is not detailed in this filing text.
Risks and Contingencies: No specific risks, contingencies, or unusual items are described in the text of this Form 8-K. The filing notes that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash burn figures for Q4 and FY 2025.
- Verify the details of the "business update" regarding clinical trial progress or pipeline milestones mentioned in the press release.
- Confirm current cash, cash equivalents, and short-term investment balances to assess runway.
- Check for any new debt covenants or financing activities disclosed in the full press release.